Connection

Yusuf Hannun to Neoplasms

Back to Details
This is a "connection" page, showing publications Yusuf Hannun has written about Neoplasms.
Yusuf Hannun
Connection Strength
2.879
Neoplasms
  1. Upregulation of sphingosine kinase 1 in response to doxorubicin generates an angiogenic response via stabilization of Snail. FASEB J. 2023 03; 37(3):e22787.
    View in: PubMed
    Score: 0.378
  2. Neutral ceramidase: Advances in mechanisms, cell regulation, and roles in cancer. Adv Biol Regul. 2019 01; 71:141-146.
    View in: PubMed
    Score: 0.280
  3. Evaluating intrinsic and non-intrinsic cancer risk factors. Nat Commun. 2018 08 28; 9(1):3490.
    View in: PubMed
    Score: 0.277
  4. Contributions of the Intrinsic Mutation Process to Cancer Mutation and Risk Burdens. EBioMedicine. 2017 10; 24:5-6.
    View in: PubMed
    Score: 0.260
  5. Substantial contribution of extrinsic risk factors to cancer development. Nature. 2016 Jan 07; 529(7584):43-7.
    View in: PubMed
    Score: 0.230
  6. Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes. Adv Biol Regul. 2015 Jan; 57:24-41.
    View in: PubMed
    Score: 0.212
  7. Evolving concepts in cancer therapy through targeting sphingolipid metabolism. Biochim Biophys Acta. 2014 Aug; 1841(8):1174-88.
    View in: PubMed
    Score: 0.200
  8. Novel chemotherapeutic drugs in sphingolipid cancer research. Handb Exp Pharmacol. 2013; (215):211-38.
    View in: PubMed
    Score: 0.187
  9. Molecular targeting of acid ceramidase: implications to cancer therapy. Curr Drug Targets. 2008 Aug; 9(8):653-61.
    View in: PubMed
    Score: 0.138
  10. Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer. 2004 Aug; 4(8):604-16.
    View in: PubMed
    Score: 0.104
  11. Bioactive sphingolipids: Advancements and contributions from the laboratory of Dr. Lina M. Obeid. Cell Signal. 2021 03; 79:109875.
    View in: PubMed
    Score: 0.081
  12. Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol. 2018 03; 19(3):175-191.
    View in: PubMed
    Score: 0.066
  13. Ceramidases, roles in sphingolipid metabolism and in health and disease. Adv Biol Regul. 2017 Jan; 63:122-131.
    View in: PubMed
    Score: 0.061
  14. Intracellular sphingosine kinase 2-derived sphingosine-1-phosphate mediates epidermal growth factor-induced ezrin-radixin-moesin phosphorylation and cancer cell invasion. FASEB J. 2015 Nov; 29(11):4654-69.
    View in: PubMed
    Score: 0.056
  15. Regulation of protein kinase C and role in cancer biology. Cancer Metastasis Rev. 1994 Dec; 13(3-4):411-31.
    View in: PubMed
    Score: 0.053
  16. Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids. Biochim Biophys Acta. 1993 Dec 21; 1154(3-4):223-36.
    View in: PubMed
    Score: 0.050
  17. Sphingosine-1-phosphate receptor 2. FEBS J. 2013 Dec; 280(24):6354-66.
    View in: PubMed
    Score: 0.049
  18. The roles of neutral sphingomyelinases in neurological pathologies. Neurochem Res. 2012 Jun; 37(6):1137-49.
    View in: PubMed
    Score: 0.044
  19. Defining a role for sphingosine kinase 1 in p53-dependent tumors. Oncogene. 2012 Mar 01; 31(9):1166-75.
    View in: PubMed
    Score: 0.042
  20. Acid ceramidase inhibition: a novel target for cancer therapy. Front Biosci. 2008 Jan 01; 13:2293-8.
    View in: PubMed
    Score: 0.033
  21. Translational aspects of sphingolipid metabolism. Trends Mol Med. 2007 Aug; 13(8):327-36.
    View in: PubMed
    Score: 0.032
  22. Sphingosine kinase: biochemical and cellular regulation and role in disease. J Biochem Mol Biol. 2006 Mar 31; 39(2):113-31.
    View in: PubMed
    Score: 0.029
  23. Role of sphingolipids in senescence: implication in aging and age-related diseases. J Clin Invest. 2018 07 02; 128(7):2702-2712.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.